Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Latest RNS from Convatec Group PLC
Analyst consensus: Buy
As of 10 Nov 2026, 19 analysts rate Convatec Group PLC a Buy, with 95% buy ratings and a mean price target of 300p (range 228p–372p), +21% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 214p against a current price of 250p (-14%), based on EV/EBITDA.